Wendy K Nevala Selected Research

Wendy K Nevala Research Topics

Disease

24	Melanoma (Melanoma, Malignant) 04/2021 - 08/2006
21	Neoplasms (Cancer) 04/2021 - 06/2007
5	Inflammation (Inflammations) 08/2015 - 03/2009
3	Hematologic Neoplasms (Hematological Malignancy) 01/2021 - 01/2016
2	Cytokine Release Syndrome 01/2021 - 01/2019
2	Nevus (Nevi) 08/2015 - 08/2014
2	Neoplasm Metastasis (Metastasis) 08/2015 - 06/2007
1	Multiple Myeloma 01/2022
1	Adenocarcinoma 01/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Persistent Infection 11/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2019
1	Neuroinflammatory Diseases 01/2019
1	Brain Neoplasms (Brain Tumor) 01/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2018
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2017
1	Hyperlipidemias (Hyperlipidemia) 08/2014
1	Endometrial Neoplasms (Endometrial Cancer) 04/2014
1	Breast Neoplasms (Breast Cancer) 04/2014
1	Ovarian Neoplasms (Ovarian Cancer) 04/2014
1	Pleural Effusion (Pleural Effusions) 10/2013

Drug/Important Bio-Agent (IBA)

8	CytokinesIBA 04/2021 - 03/2009
5	Peptides (Polypeptides)IBA 01/2020 - 08/2006
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 08/2006
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 03/2009
4	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 04/2021 - 06/2007
4	Immune Checkpoint InhibitorsIBA 04/2021 - 01/2015
4	VaccinesIBA 01/2020 - 08/2006
4	ChemokinesIBA 01/2018 - 05/2013
3	Biological ProductsIBA 04/2021 - 01/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2017
3	AntigensIBA 11/2020 - 12/2008
3	Protein Subunit VaccinesIBA 01/2020 - 08/2006
3	Interleukin-2 (IL2)IBA 07/2018 - 10/2011
3	Bevacizumab (Avastin)FDA Link 01/2017 - 05/2013
3	Temozolomide (Temodar)FDA LinkGeneric 08/2014 - 01/2012
2	B-Cell Maturation AntigenIBA 01/2022 - 01/2021
2	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2020 - 01/2015
2	RNA (Ribonucleic Acid)IBA 01/2017 - 03/2009
2	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2012
2	AntibodiesIBA 01/2017 - 01/2016
2	Monoclonal AntibodiesIBA 01/2017 - 05/2013
2	Carboplatin (JM8)FDA LinkGeneric 01/2017 - 05/2013
2	Albumin-Bound Paclitaxel FDA Link 01/2016 - 05/2013
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 05/2013 - 04/2011
2	Monatide (IMS 3015)IBA 10/2011 - 08/2006
2	HLA-A2 Antigen (HLA A2 Antigen)IBA 12/2008 - 08/2006
1	Interleukin-8 (Interleukin 8)IBA 04/2021
1	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2021
1	RamucirumabIBA 01/2021
1	glucopyranosyl lipid-AIBA 01/2020
1	EmulsionsIBA 01/2020
1	resiquimodIBA 01/2019
1	EpitopesIBA 01/2019
1	IpilimumabIBA 07/2018
1	pembrolizumabIBA 07/2018
1	Complementarity Determining Regions (Complementarity Determining Region)IBA 01/2018
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2018
1	AlbuminsIBA 01/2017
1	Calgranulin BIBA 01/2017
1	Rituximab (Mabthera)FDA Link 01/2017
1	Liposomes (Liposome)IBA 01/2017
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2017
1	Interleukin-15 (Interleukin 15)IBA 01/2017
1	130-nm albumin-bound paclitaxelIBA 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 10/2016
1	MucinsIBA 10/2016
1	LigandsIBA 01/2016
1	Immunoglobulin G (IgG)IBA 01/2016
1	Cancer VaccinesIBA 01/2015
1	Neutralizing AntibodiesIBA 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Chemokine CCL22IBA 01/2015
1	Alkylating AgentsIBA 08/2014
1	Sirolimus (Rapamycin)FDA Link 08/2014
1	Everolimus FDA Link 08/2014
1	TOR Serine-Threonine KinasesIBA 08/2014
1	Gonadal Steroid Hormones (Sex Hormones)IBA 04/2014
1	Platinum Compounds (Compounds, Platinum)IBA 10/2012
1	taxaneIBA 10/2012
1	C-Reactive ProteinIBA 01/2012
1	SurvivinIBA 10/2011
1	Interleukin-10 (Interleukin 10)IBA 03/2009
1	Interleukin-13IBA 03/2009
1	Interleukin-5 (Interleukin 5)IBA 03/2009
1	InterleukinsIBA 03/2009
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2008
1	sargramostim (Leukine)FDA Link 12/2008
1	ThrombospondinsIBA 06/2007
1	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 06/2007
1	NAc- Sar- Gly- Val- (d- allo- Ile)- Thr- Nva- Ile- Arg- ProNEt (ABT 510)IBA 06/2007
1	Differentiation AntigensIBA 08/2006

Therapy/Procedure

12	Therapeutics 04/2021 - 12/2008
7	Drug Therapy (Chemotherapy) 09/2019 - 01/2012
5	Immunotherapy 01/2019 - 03/2009
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2022 - 01/2021
1	Cryosurgery 01/2017
1	Radiofrequency Ablation 01/2017
1	Intravenous Administration 10/2012